MOS vs STRO
The Mosaic Company (MOS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MOS and STRO stock pages for the full models.
Not investment advice.